Skip to main content
Natera, Inc. logo

Natera, Inc. — Investor Relations & Filings

Ticker · NTRA ISIN · US6323071042 LEI · 529900CQ3OZ0A0VYVU59 US Human health and social work activities
Filings indexed 1,585 across all filing types
Latest filing 2019-09-11 Director's Dealing
Country US United States of America
Listing US NTRA

About Natera, Inc.

https://www.natera.com/

Natera, Inc. is a diagnostics company specializing in cell-free DNA (cfDNA) testing. The company develops and commercializes non-invasive tests focused on three primary areas: women's health, oncology, and organ health. In women's health, its products include the Panorama non-invasive prenatal test (NIPT) and the Horizon carrier screening test to assess genetic risks. The oncology portfolio features Signatera, a personalized molecular residual disease (MRD) test used to monitor cancer recurrence and treatment response. For organ health, its tests are designed to detect early signs of transplant rejection. Natera's technology aims to provide actionable information for personalized medical care, supported by extensive clinical validation through numerous peer-reviewed studies.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2019-09-11 English
4 Filing
Director's Dealing
2019-09-11 English
4 Filing
Director's Dealing
2019-09-06 English
4 Filing
Director's Dealing
2019-09-03 English
3 Filing
Director's Dealing
2019-08-23 English
8-K Filing
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated August 15, 2019, reporting the appointment of a new director to the Board of Directors of Natera, Inc. The key section is Item 5.02, which specifically addresses the departure and appointment of directors or certain officers. The content details the increase in board size and the appointment of Dr. Rowan E. Chapman as a director, including terms and compensation references. There is no financial data or earnings information, nor is this a full annual or quarterly report. The document is clearly an announcement of changes in the company's board of directors, fitting the category of Board/Management Information (MANG). The document length (6065 characters) and content confirm it is not a brief announcement or a certification but a substantive filing about management changes.
2019-08-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.